|
|
|
Volumn 24, Issue 2, 1997, Pages 145-155
|
|
Anti-tumor activity of farnesyl transferase inhibitor
a
a
EISAI CO LTD
(Japan)
|
|
Author keywords
Anti tumor; Farnesyl transferase; Posttranslational processing; Ras mutation
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
PRODRUG;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
PROTEIN P21;
RAS PROTEIN;
ANCHORAGE INDEPENDENT GROWTH;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
CANCER GROWTH;
CELL STRAIN 3T3;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG SCREENING;
GENE MUTATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MOUSE;
NONHUMAN;
ONCOGENE H RAS;
ONCOGENE K RAS;
ONCOGENE N RAS;
ONCOGENE RAS;
PROTEIN PROCESSING;
TUMOR CELL LINE;
TUMOR XENOGRAFT;
ALKYL AND ARYL TRANSFERASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
FARNESYLTRANSTRANSFERASE;
HUMANS;
METHIONINE;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
OLIGOPEPTIDES;
ONCOGENE PROTEIN P21(RAS);
PROTEIN PROCESSING, POST-TRANSLATIONAL;
TRANSFERASES;
TUMOR CELLS, CULTURED;
|
|
EID: 0030820894
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (14)
|
